Rosuline

📦 Hver ordre er dækket af vores Reshipment Assurance Policy — hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.

Hvorfor bestille fra MedsBase

Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomspændende i diskret, neutral emballage — ingen medicinnavn på pakkens ydre. Kortbetalinger håndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor — aldrig “MedsBase” eller medicinnavn). Crypto og SEPA bankoverførsel accepteres også. Hver ordre er dækket af vores Reshipment Assurance Policy.

What Is Rosuline?

Rosuline is an oral 5 / 10 mg rosuvastatin tablet from Torrent Pharma, supplied in 30-180 tablets. Rosuvastatin was introduced by AstraZeneca in 2003 as Crestor. Hydrophilic statin; primarily excreted unchanged in faeces (10% renal, 90% biliary); minimal CYP metabolism (mostly CYP2C9 modestly). Dose range 5-40 mg once daily; 20-40 mg are high-intensity.

How Rosuvastatin Works

Rosuvastatin inhibits HMG-CoA-reduktase, the rate-limiting enzyme of hepatic cholesterol biosynthesis. Downstream:

• Reduced intracellular cholesterol in hepatocytes — triggers sterol-regulatory element binding protein (SREBP) activation and upregulation of LDL-receptor expression on the hepatocyte surface
• Increased clearance of circulating LDL-C — the primary LDL-lowering mechanism
• Modest triglyceride reduction (10-20%) and modest HDL rise (5-10%)
• Pleiotropic effects beyond LDL-lowering — reduced vascular inflammation (hs-CRP drop), improved endothelial function, plaque stabilisation, reduced platelet reactivity. The magnitude of the clinical benefit across trials exceeds what is explained by LDL-C change alone.

Rosuline Dosage

Primary prevention (no prior CV event): start 5-10 mg once daily; titrate to target based on 10-year ASCVD risk. For diabetics or ASCVD risk >7.5%, moderate-intensity (10-20 mg) is typical.

Secondary prevention (prior MI, stroke, PAD, or diabetic CVD): high-intensity therapy — 20-40 mg once daily. Target LDL-C <1.8 mmol/L (<70 mg/dL) per 2019 ESC and <1.4 mmol/L (<55 mg/dL) for very-high-risk ASCVD per 2021 ESC update.

Familial hypercholesterolaemia: maximum-tolerated statin (usually 40 mg) often combined with ezetimibe 10 mg and/or PCSK9 inhibitor (alirocumab/evolocumab/inclisiran) to achieve guideline targets.

Administration: once daily with or without food. Any time of day — 19-hour half-life means timing does not meaningfully change efficacy.

Overvågning:

• Baseline: full lipid panel, LFTs (ALT), creatine kinase (CK), HbA1c or fasting glucose, creatinine, thyroid-stimulating hormone (TSH) if not recently checked.
• 4-12 uger: repeat lipids to assess response. Expect rosuvastatin 20 mg reduces LDL-C by 52%; 40 mg by 55% — the most potent statin per mg. Dose-escalate if target not met.
• Årligt: lipids, LFTs (unless symptomatic). CK only on muscle complaints, not routinely.
• Stop og undersøg: CK >10× ULN, ALT >3× ULN and rising, persistent unexplained muscle pain with CK >5× ULN, rhabdomyolysis (dark urine, profound weakness).

Evidence for Rosuvastatin

JUPITER (2008) — rosuvastatin 20 mg in 17,802 patients with normal LDL but elevated hs-CRP reduced CV events by 44%; extended statin indications to “inflammation-driven” risk. ASTEROID (2006) — 40 mg for 24 months produced measurable coronary plaque regression on IVUS. SATURN (2011) — rosuvastatin 40 mg vs atorvastatin 80 mg; rosuvastatin slightly greater LDL reduction but no meaningful regression advantage. HOPE-3 (2016) — rosuvastatin 10 mg primary prevention in intermediate-risk patients reduced CV events by 24%.

Godkendte og evidensbaserede anvendelser

• Primary and secondary prevention of cardiovascular disease
• Inflammation-driven risk with elevated hs-CRP (JUPITER)
• Patients who are CYP3A4-interaction-prone (simpler pharmacology than atorvastatin)
• Familial hyperkolesterolæmi

Practical Considerations

Fewer CYP3A4 interactions than atorvastatin — a practical advantage when patients take macrolides, azoles, or certain antiretrovirals. Dose-capped in Asian patients — the FDA reduced the Asian starting dose to 5 mg after pharmacokinetic studies showed 2-fold higher plasma levels. Creatine kinase and LFT monitoring as for all statins.

Bivirkninger

Almindelige (>1%):

• Myalgia (muscle pain) — bothersome in 5-10% of users; confirmed statin-associated muscle symptoms with CK rise in 0.1-1%. High nocebo component: SAMSON trial (2020) showed no difference between statin and placebo in double-blind n-of-1 crossovers in many “statin-intolerant” patients.
• Let forhøjelse af transaminaser — 3% have ALT rise below 3× ULN; usually transient and does not require dose change.
• New-onset diabetes — absolute excess ~0.2 per 100 patient-years, mostly in prediabetic patients. CV benefit far exceeds diabetes risk.
• Headache, dyspepsia, nausea
• Anvendelser og indikationer (uncommon; mechanism unclear)
• Sleep disturbance, cognitive fog (reported but not consistent in RCTs)

Ikke almindelige, men klinisk vigtige:

• Rabdomyolyse (<1 per 10,000 patient-years) — severe muscle breakdown, renal failure risk. Stop immediately on dark urine + profound weakness + CK >10× ULN.
• Immunmedieret nekrotiserende myopati — rare persistent myopathy that continues after stopping statin; anti-HMGCR antibody mediated. Needs immunosuppressive treatment.
• Severe transaminitis / drug-induced liver injury — rare; stop if ALT >3× ULN with symptoms or rising trajectory.
• Perifer neuropati (sjældent)

Kontraindikationer

• Graviditet og amning — statins are contraindicated; cholesterol is required for fetal neurodevelopment.
• Aktiv leversygdom or unexplained persistent ALT >3× ULN.
• Prior rhabdomyolysis or severe statin-intolerance confirmed in double-blind rechallenge.
• Concurrent strong CYP3A4 inhibitors (for rosuvastatin): clarithromycin, itraconazole, ritonavir — hold statin or switch to rosuvastatin/pravastatin.
• Hypersensitivity to the statin.

Lægemiddelinteraktioner

• CYP2C9 and OATP1B1 transporter interactions — ciclosporin, gemfibrozil, and some antiretrovirals raise rosuvastatin levels. Dose-cap rosuvastatin at 5 mg with ciclosporin; avoid with gemfibrozil.
• Grapefrugtjuice — minimal interaction with rosuvastatin (hydrophilic; minimal CYP3A4 metabolism).
• Fibrates (gemfibrozil, fenofibrate) — additive myopathy risk. Gemfibrozil is the worst; fenofibrate is the preferred fibrate for combination. Reserve combinations for specialist dyslipidaemia care.
• Niacin high-dose — additive myopathy risk. Low-dose niacin (1-2 g) usually tolerated.
• Warfarin — small INR rise with statin initiation; check INR 1 week after starting. Not a contraindication.
• Digoxin — small digoxin level rise with atorvastatin (P-glycoprotein); usually not clinically significant.
• Alkohol — heavy intake raises liver injury risk. Moderate intake is acceptable.

Opbevaring

Store Rosuline below 25°C in the original blister pack. Keep out of reach of children.

Ofte stillede spørgsmål

Do I have to take Rosuline at night?

No — rosuvastatin has a 19-hour half-life, long enough that the ~24-hour cycle of nocturnal cholesterol synthesis is covered regardless of dose timing. Morning dosing with other medications is fine. The “take statins at night” rule comes from short-half-life statins (simvastatin, lovastatin).

What if I get muscle aches on Rosuline?

Common and rarely dangerous. Check creatine kinase (CK). If CK is normal, the pains are usually not statin-related — the SAMSON trial (2020) showed most “statin-intolerant” patients had equal aches on placebo in double-blind crossover. Options: continue statin with vitamin D supplementation (if deficient), try coenzyme Q10 (weak evidence but low-risk), switch statin (rosuvastatin has lower muscle-symptom rate than simvastatin and atorvastatin in some trials), lower the dose, or adopt alternate-day dosing. Only stop if CK >10× ULN, symptoms are disabling, or there is objective weakness.

Will Rosuline give me diabetes?

Statins cause a small excess of new-onset diabetes — approximately 1 extra diabetes case per 1,000 people per year, mostly in those already at high diabetes risk (overweight, prediabetes, family history). The same treatment prevents roughly 5-10 cardiovascular events per 1,000 people per year in the same populations — so the net benefit is strongly positive. Do not stop a statin because of diabetes risk alone.

Can I take Rosuline with grapefruit juice?

Yes — rosuvastatin has minimal CYP3A4 metabolism, so the grapefruit interaction is minor. Contrast with atorvastatin where regular grapefruit consumption is discouraged.

How long will I need to take Rosuline?

Indefinitely, in almost all cases. Stopping a statin causes LDL-C to rebound within weeks and cardiovascular protection is lost within months. Statins are lifelong preventive therapy for atherosclerotic disease, not a short course.

Can I take Rosuline in pregnancy?

No — statins are contraindicated in pregnancy and breastfeeding. Cholesterol is required for fetal neurodevelopment; statins cross the placenta. Stop the statin before planned pregnancy; if pregnancy is unplanned, stop immediately and discuss risks with a specialist. Familial hypercholesterolaemia patients can usually safely defer statin therapy during pregnancy and breastfeeding.

Where can I buy Rosuline online?

You can buy Rosuline (rosuvastatin 5 / 10 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Relaterede hjerte- og blodtryksmedicin

• Aldactone — Spironolacton (ikke-selektiv MR-antagonist)
• Amlopres AT — Amlodipin + Atenolol kombination
• Aten — Atenolol (betablokker)
• Ecosprin — Aspirin 75/150 mg
• Eptus — Eplerenon 25/50 mg (selektiv MR-antagonist)
• Lotensyl — Cilnidipine 10/20 mg (L+N-type CCB)
• Se alle højtryksmedicin

Hvorfor bestille fra MedsBase

Rosuline is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Reshipment Assurance Policy. Din betalingsbeskrivelse ved kortbetaling viser den regulerede betalingsprocessor (en reguleret kortbetalingsprocessor), aldrig “MedsBase” eller noget medicinsk produktnavn.

Relaterede alternativer

Andre produkter inden for Kroniske tilstande som kunder også ser:

• Triohale Inhaler
• Montair
• Lomoother
• Unicontin-E
• Ventocortil

Flere muligheder inden for behandling af højt kolesterol

Rangeret efter seneste MedsBase ordrevolumen — hvad andre kunder i denne kategori vælger.

Ezedoc

US$36.00 – US$124.00Ártartomány: US$36.00 és US$124.00 között

Lipvas

US$12.00 – US$117.00Ártartomány: US$12.00 és US$117.00 között

Choltran Sachet

US$24.00 – US$94.00Ártartomány: US$24.00 és US$94.00 között

Lipicard

US$34.00 – US$175.00Ártartomány: US$34.00 és US$175.00 között